IS2597B - Lyf samsett úr R,R-formóteróli og siklesóníði - Google Patents

Lyf samsett úr R,R-formóteróli og siklesóníði

Info

Publication number
IS2597B
IS2597B IS7910A IS7910A IS2597B IS 2597 B IS2597 B IS 2597B IS 7910 A IS7910 A IS 7910A IS 7910 A IS7910 A IS 7910A IS 2597 B IS2597 B IS 2597B
Authority
IS
Iceland
Prior art keywords
formoterol
cyclesonide
medicines composed
medicines
salt
Prior art date
Application number
IS7910A
Other languages
English (en)
Other versions
IS7910A (is
Inventor
Klaus Dietzel
Degenhard Marx
Helgert Mueller
Christian Weimar
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of IS7910A publication Critical patent/IS7910A/is
Publication of IS2597B publication Critical patent/IS2597B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Glass Compositions (AREA)
IS7910A 2002-12-12 2005-06-23 Lyf samsett úr R,R-formóteróli og siklesóníði IS2597B (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02027797 2002-12-12
DE10306213 2003-02-13
PCT/EP2003/014045 WO2004052374A1 (en) 2002-12-12 2003-12-11 Combination medicament

Publications (2)

Publication Number Publication Date
IS7910A IS7910A (is) 2005-06-23
IS2597B true IS2597B (is) 2010-03-15

Family

ID=32509778

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7910A IS2597B (is) 2002-12-12 2005-06-23 Lyf samsett úr R,R-formóteróli og siklesóníði

Country Status (15)

Country Link
US (2) US7879833B2 (is)
EP (1) EP1572217B1 (is)
JP (1) JP4755495B2 (is)
AT (1) ATE405275T1 (is)
AU (1) AU2003293833B2 (is)
CA (1) CA2508692C (is)
DE (1) DE60323138D1 (is)
DK (1) DK1572217T3 (is)
ES (1) ES2312844T3 (is)
HR (1) HRP20050611B1 (is)
IS (1) IS2597B (is)
PL (1) PL375819A1 (is)
PT (1) PT1572217E (is)
RS (1) RS51707B (is)
WO (1) WO2004052374A1 (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8025896B2 (en) 2001-07-16 2011-09-27 Depuy Products, Inc. Porous extracellular matrix scaffold and method
GB0312148D0 (en) 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
WO2004110460A1 (en) 2003-06-13 2004-12-23 Altana Pharma Ag Formoterol and ciclesonide combination
GB0315889D0 (en) 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
PT1670482E (pt) 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
CA2579007A1 (en) * 2004-09-10 2006-03-16 Altana Pharma Ag Ciclesonide and syk inhibitor combination and methods of use thereof
WO2011093814A2 (en) * 2010-01-29 2011-08-04 Mahmut Bilgic A pharmaceutical combination comprising formoterol and ciclesonide
KR20180028563A (ko) * 2010-10-12 2018-03-16 시플라 리미티드 약학 조성물

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0039123B1 (en) 1980-02-27 1984-10-03 TATE & LYLE PUBLIC LIMITED COMPANY Crystalline glucose and process for its production
US4816445A (en) 1984-06-21 1989-03-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Crystalline alpha-maltose
JP2518646B2 (ja) 1987-05-29 1996-07-24 株式会社 林原生物化学研究所 マルト−ス粉末の製造方法
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
ATE111364T1 (de) 1989-05-31 1994-09-15 Fisons Plc Medikament und inhalationsvorrichtung dafür.
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
JP3042866B2 (ja) 1989-09-08 2000-05-22 グラクソ・グループ・リミテッド 呼吸疾患治療薬
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
US6536427B2 (en) 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
US5178866A (en) 1990-03-23 1993-01-12 Alza Corporation Dosage form for delivering drug to the intestine
WO1992001477A1 (en) * 1990-07-26 1992-02-06 G.D. Searle & Co. Polymeric drug delivery system
GR1001529B (el) 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
US5434304A (en) 1990-09-26 1995-07-18 Aktiebolaget Astra Process for preparing formoterol and related compounds
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
US5795564A (en) 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US6866839B2 (en) 1991-04-05 2005-03-15 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
CA2111002C (en) 1991-06-10 2000-08-22 Julianne Fassberg Non-chlorofluorocarbon aerosol formulations
IT1250691B (it) 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
DK0613371T3 (da) 1991-12-18 2002-05-13 Astrazeneca Ab Ny kombination af formoterol og budesonid
GB9213874D0 (en) 1992-06-30 1992-08-12 Fisons Plc Process to novel medicament form
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
DK0701565T3 (da) 1993-04-02 1999-07-12 Byk Gulden Lomberg Chem Fab Nye prednisolonderivater
IL111194A (en) 1993-10-08 1998-02-08 Fisons Plc Process for the production of medicament formulations
DE19541689A1 (de) * 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
US5811388A (en) 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
ES2247604T3 (es) 1995-06-12 2006-03-01 G.D. SEARLE & CO. Composiciones que comprenden un inhibidor de ciclooxigenasa-2 y un inhibidor de 5-lipoxigenasa.
AU7095296A (en) 1995-09-26 1997-04-17 Takeda Chemical Industries Ltd. Phosphorylamides, their preparation and use
DE19635498A1 (de) 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
SE9603725D0 (sv) 1996-10-11 1996-10-11 Astra Ab New teatment
US6380222B2 (en) 1996-10-11 2002-04-30 Astrazeneca Ab Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps
FR2754712B1 (fr) 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
WO1998021175A1 (en) 1996-11-11 1998-05-22 Sepracor, Inc. Process for the preparation of optically pure isomers of formoterol
US6613795B2 (en) 1996-11-11 2003-09-02 Christian Noe Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
US6040344A (en) 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
SE9700135D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
US20020111495A1 (en) * 1997-04-04 2002-08-15 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
US6120752A (en) 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
GB2329939A (en) 1997-06-26 1999-04-07 Glaxo Group Ltd Self-lubricating valve stem for aerosol containers
US6470894B2 (en) 1997-09-19 2002-10-29 Thione International, Inc. Glutathione, green tea, grape seed extract to neutralize tobacco free radicals
ES2175799T3 (es) 1997-10-08 2002-11-16 Sepracor Inc Forma de dosificacion para administracion en aerosol.
SE9704186D0 (sv) 1997-11-14 1997-11-14 Astra Ab New composition of matter
EP1054004B1 (en) 1997-12-15 2008-07-16 Astellas Pharma Inc. Novel pyrimidine-5-carboxamide derivatives
SE9801368D0 (sv) 1998-04-20 1998-04-20 Astra Ab New use
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6241969B1 (en) 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
ES2234266T3 (es) 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
JP4672143B2 (ja) 1998-08-04 2011-04-20 ヤゴテック アーゲー 医薬用エーロゾル製剤
US6436953B1 (en) 1998-09-23 2002-08-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyridoethers
PL200941B1 (pl) * 1998-11-13 2009-02-27 Jagotec Ag Suchy proszkowy preparat inhalacyjny
US6352152B1 (en) 1998-12-18 2002-03-05 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6124268A (en) 1999-02-17 2000-09-26 Natreon Inc. Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
JP2001048807A (ja) 1999-08-04 2001-02-20 Wakamoto Pharmaceut Co Ltd 難溶性薬物を水に溶解してなる製剤
DE19947234A1 (de) 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und Antihistaminika
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
GB0002336D0 (en) 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
GB0009607D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Medical compositions
GB0012261D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
GB0015043D0 (en) 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
FI20002177A0 (fi) 2000-10-02 2000-10-02 Orion Yhtymae Oyj Uusi yhdistelmä astman hoitoon
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20020183292A1 (en) 2000-10-31 2002-12-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and corticosteroids
US6528527B2 (en) 2000-11-07 2003-03-04 Merck & Co., Inc. Method of treatment with a combination of a PDE4 inhibitor and a leukotriene antagonist
CZ305498B6 (cs) 2000-12-22 2015-11-04 Glaxo Group Limited Kontejner a balení zahrnující inhalátor odměřených dávek
DE60221640T2 (de) * 2001-02-06 2008-05-21 Innovata Biomed Ltd., St. Albans Bimodale trockenpulverzusammensetzung zur inhalation
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
WO2003006310A1 (fr) 2001-07-13 2003-01-23 Tfe Techniques Et Fabrications Electroniques Dispositif destine a indiquer acoustiquement a un plongeur equipe d'un scaphandre la pression de gaz de respiration dans le reservoir et/ou la pression hydrostatique
WO2003035030A1 (en) 2001-10-24 2003-05-01 Pari Gmbh Kit for the preparation of a pharmaceutical composition
KR20050044503A (ko) 2001-11-17 2005-05-12 아벤티스 파마 리미티드 흡착제 및 이의 용도
CA2467652A1 (en) 2001-11-19 2003-05-30 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
ITMI20020808A1 (it) 2002-04-17 2003-10-17 Chiesi Farma Spa Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione
EP3513813A1 (en) 2002-07-02 2019-07-24 Astrazeneca Ciclesonide-containing sterile aqueous suspension
CA2495830C (en) 2002-08-30 2012-08-21 Altana Pharma Ag The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
AU2004241746A1 (en) 2003-05-22 2004-12-02 Nycomed Gmbh Salmeterol and ciclesonide combination
GB0312148D0 (en) 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
WO2004110460A1 (en) 2003-06-13 2004-12-23 Altana Pharma Ag Formoterol and ciclesonide combination
GB0315889D0 (en) 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
PT1670482E (pt) 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias

Also Published As

Publication number Publication date
CA2508692C (en) 2012-04-03
PL375819A1 (en) 2005-12-12
JP2006514686A (ja) 2006-05-11
WO2004052374A1 (en) 2004-06-24
IS7910A (is) 2005-06-23
RS51707B (sr) 2011-10-31
US7879833B2 (en) 2011-02-01
HRP20050611B1 (hr) 2013-12-20
EP1572217B1 (en) 2008-08-20
RS20050429A (sr) 2007-12-31
ES2312844T3 (es) 2009-03-01
DK1572217T3 (da) 2008-12-15
ATE405275T1 (de) 2008-09-15
DE60323138D1 (de) 2008-10-02
US20110086827A1 (en) 2011-04-14
PT1572217E (pt) 2008-11-28
US20060025392A1 (en) 2006-02-02
HRP20050611A2 (en) 2006-09-30
US8258124B2 (en) 2012-09-04
AU2003293833A1 (en) 2004-06-30
EP1572217A1 (en) 2005-09-14
JP4755495B2 (ja) 2011-08-24
CA2508692A1 (en) 2004-06-24
AU2003293833B2 (en) 2009-10-01

Similar Documents

Publication Publication Date Title
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
DE69925133D1 (de) Pyrrolobenzodiazepine
NO20052855D0 (no) Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav.
BR0303390B1 (pt) retrator abdominal.
SE0301653D0 (sv) Novel compounds
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
ATE231872T1 (de) Thiazolopyrimidinderivate
UY28312A1 (es) Pirazolopirimidinas sustituidas con 6-ciclimetilo y 6-alquilmetilo
DE60334632D1 (de) Mechanolumineszenzstoff und dessen herstellung
IS2597B (is) Lyf samsett úr R,R-formóteróli og siklesóníði
RU2002107079A (ru) Вещество, обладающее седативным действием
PL371784A1 (en) Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
TR200402030T4 (tr) İkame edilen I-aminobutan-3-ol-türevleri
DE50301937D1 (de) Sende- und Empfangsanordnung mit kanalorientierter Verbindung
AU2003260566A1 (en) Phenyl-furan or phenyl-thiophene derivatives, their preparation and their use as medicine
BRPI0411382A (pt) derivados de 2-aminobenzoil
ATE270551T1 (de) Kombinationspräparat aus 2-methylthiazolidin-2,4- dicarbonsäure und paracetamol
BR0116646B1 (pt) aperfeiÇoamento da integridade de emplastro pela substituiÇço do adesivo construtivo com compressÕes ultrassânicas.
EA200100317A1 (ru) Новые производные бензоилгуанидина с эффективными свойствами, способ их получения и их применение при изготовлении лекарственных средств
DE60319388D1 (de) C6- UND C9-SUBSTITUIERTE CHROMENOÄ4,3-cÜISOXAZOLIN
NO20061944L (no) Ny assosiasjon av et antiaterotrombotisk middel og et antiplateaggregerede middel
TW200510461A (en) Disialoundecaglycosylasparagine - fatty acid amide and medicine containing the same
ES1052634Y (es) Peladora de almendra, semilla de albaricoque y productos similares.
BRPI0410638A (pt) derivados de azitromicina
RU2002117643A (ru) Люплатекс, обладающий противолучевыми свойствами